BlackRock Inc. - GEMPHIRE THERAPEUTICS INC ownership

GEMPHIRE THERAPEUTICS INC's ticker is GEMP and the CUSIP is 36870A108. A total of 39 filers reported holding GEMPHIRE THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of GEMPHIRE THERAPEUTICS INC
ValueSharesWeighting
Q3 2019$246,000
-53.1%
644,589
-0.5%
0.00%
Q2 2019$525,000
-32.1%
648,029
-3.6%
0.00%
Q1 2019$773,000
+41.3%
672,572
-0.3%
0.00%
Q4 2018$547,000
-60.7%
674,490
-0.1%
0.00%
Q3 2018$1,391,000
+368.4%
675,038
+2210.5%
0.00%
Q2 2018$297,000
+172.5%
29,216
+74.3%
0.00%
Q1 2018$109,000
-18.7%
16,7580.0%0.00%
Q4 2017$134,000
-12.4%
16,758
+4.1%
0.00%
Q3 2017$153,000
-29.8%
16,094
-5.4%
0.00%
Q2 2017$218,000
+169.1%
17,007
+122.1%
0.00%
Q1 2017$81,0007,6560.00%
Other shareholders

There were no reported owners of GEMPHIRE THERAPEUTICS INC in Q2 2018.

NameSharesValueWeighting ↓
View complete list of GEMPHIRE THERAPEUTICS INC shareholders